查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
电脑辅助诊断的按全球市场 - 产业规模，占有率，趋势，机会，预测:各显像模式，各用途，各企业，各地区(2017年～2027年)
市场调查报告书
商品编码
1166580

电脑辅助诊断的按全球市场 - 产业规模，占有率，趋势，机会，预测:各显像模式，各用途，各企业，各地区(2017年～2027年)

Computer Aided Detection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Imaging Modality, By Application, By Company and By Region
出版日期: | 出版商: TechSci Research | 英文 117 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球电脑辅助诊断市场，预计从2023年到2027年的预测期间内完成惊人的成长。

主要原因，是慢性疾病的发生率上升和技术的进步等，推动全球市场成长。支撑市场成长的其他因素，是认识度的提高，投资的扩大，人口增加，生活方式的变化，无机性成长策略的采用增加，对医疗基础设施的政府支援等。还有健康保险和医疗旅游业的需求慢慢高涨，也将是促进市场成长的重要要素之一。

本报告提供全球电脑辅助诊断市场相关调查，各市场区隔分析，市场动态，企业简介等资讯。

目录

第1章 产品概要

第2章 调查手法

第3章 COVID-19对全球电脑辅助诊断市场的影响

第4章 VOC (客户的迴响)

第5章 摘要整理

第6章 全球电脑辅助诊断市场预测

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各显像模式(乳房X光摄影，MRI，超音波，断层摄影，其他)
    • 各用途(肿瘤学，心血管疾病，神经疾病)
    • 各企业(2021年)
    • 各地区
  • 市场地图

第7章 北美的电脑辅助诊断市场预测

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各显像模式(乳房X光摄影，MRI，超音波，断层摄影，其他)
    • 各用途(肿瘤学，心血管疾病，神经疾病)
    • 各国
  • 北美:各国分析
    • 美国
    • 墨西哥
    • 加拿大

第8章 欧洲的电脑辅助诊断市场预测

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各显像模式(乳房X光摄影，MRI，超音波，断层摄影，其他)
    • 各用途(肿瘤学，心血管疾病，神经疾病)
    • 各国
  • 欧洲:各国分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第9章 亚太地区的电脑辅助诊断市场预测

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各显像模式(乳房X光摄影，MRI，超音波，断层摄影，其他)
    • 各用途(肿瘤学，心血管疾病，神经疾病)
    • 各国
  • 亚太地区:各国分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第10章 南美的电脑辅助诊断市场预测

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各显像模式(乳房X光摄影，MRI，超音波，断层摄影，其他)
    • 各用途(肿瘤学，心血管疾病，神经疾病)
    • 各国
  • 南美:各国分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第11章 中东、非洲的电脑辅助诊断市场预测

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各显像模式(乳房X光摄影，MRI，超音波，断层摄影，其他)
    • 各用途(肿瘤学，心血管疾病，神经疾病)
    • 各国
  • 中东、非洲:各国分析
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国

第12章 市场动态

  • 促进因素
  • 课题

第13章 市场趋势与发展

第14章 竞争情形

  • Hologic Inc.
  • GE Healthcare
  • Agfa-Gevaert N.V
  • iCAD, Inc.
  • Invivo Corporation
  • McKesson Corporation
  • Siemens Healthineers AG
  • EDDA technology, Inc.
  • FUJIFILM Medical Systems U.S.A., Inc.
  • Koninklijke Philips N.V.

第15章 策略性建议

简介目录
Product Code: 12999

The global computer aided detection market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include rise in incidences of chronic diseases and technological advancements, which are bolstering the growth of the market, globally. Computer aided detection (CAD) is a group of algorithms that use pattern identification to help physicians understand medical images. The computer aided detection software helps in the early diagnosis of various diseases such as cardiovascular diseases, cancer, chronic diseases, and neurological diseases through the imaging modalities, such as magnetic resonance imaging, x-rays imaging, ultrasound imaging, and computed tomography. The other factors supporting the market's growth are increasing awareness, growing investments, increase in population, changing lifestyle, increasing adoption of inorganic growth strategies and support from governments for healthcare infrastructure. Also, the gradual surge in demand for health insurance and medical tourism are some of the key factors that are projected to bolster the market growth.

Rising Prevalence of Chronic Diseases

Rising incidence of various chronic diseases such as stroke, various types of cancers, cardiovascular disorders, and neurological dysfunctions are increasing the demand of computer-aided detection, which propels the market growth, globally. Owing to the rapid change in lifestyles and environment, the number of cancer cases such as lung cancer, cervical cancer, breast cancer, prostate, and leukemia, are rising which enables the need for CAD. According to WHO, there is a probability of a 30% rise in the number of cancer cases by 2038. Computer-aided detection system assist doctors to detect cancer at early stages, reduce mortality rates for cancer and other diseases and also helps in decreasing the false negative rate, due to which people and multispecialty hospitals are opting for diagnostic imaging techniques. Thus, in turn, bolstering the growth of the market. According to the CDC, in the U.S., roughly 210,828 people were detected with lung cancer, including 99,433 women and 111,395 men. Also, in the U.S., 157,423 people died from lung cancer. Furthermore, due to the growing awareness among the patients about successful cancer treatment, is also a contributing factor for the growth of the market.

Technological Advancements and Increasing Investments

Over the past few years, rapid technological advancements are done in healthcare sector, which propels the market growth. Technological advancements like evolution of artificial intelligence (AI) and increase in sensitivity are projected to strengthen the continuous development of the global CAD market. For instance, in 2020, a study in work with data sets from the U.S. and the United Kingdom (U.K.) revealed that the AI model was able to successfully screen for breast cancer using only the pixel data given. Medical researchers and physicians are using medical imaging devices which are coupled with computer aided detection. Owing to the demand for error free detection, the demand for computational assistance is rising. Therefore, advanced digital imaging techniques are being improved for the better effectiveness and efficiencies of CAD solutions. In addition to these, major investments in R&D of computer aided detection with 3D imaging is augmenting the growth of the market.

Market Segmentation

The global computer aided detection market is segmented into imaging modality, application, and company. Based on imaging modality, the market is divided into mammography, MRI, ultrasound, tomosynthesis, and others. Based on application, the market is divided into oncology, cardiovascular diseases, and neurological disorders. Based on oncology, the market is further divided into breast cancer, lung cancer, colorectal cancer, prostate cancer, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rise in incidence of various types of cancer in the country.

Market Players

Hologic Inc., GE Healthcare, Agfa-Gevaert N.V, iCAD, Inc., Invivo Corporation, McKesson Corporation, Siemens Healthineers AG, EDDA technology, Inc., FUJIFILM Medical Systems U.S.A., Inc., and Koninklijke Philips N.V. are some of the leading companies operating in the market.

Report Scope:

In this report, global computer aided detection market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Computer Aided Detection Market, By Imaging Modality:

Mammography

MRI

Ultrasound

Tomosynthesis

Others

  • Computer Aided Detection Market, By Application:

Oncology

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Others

Cardiovascular Diseases

Neurological Disorders

  • Computer Aided Detection Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Asia-Pacific

  • China
  • India
  • Japan
  • Australia
  • South Korea

Europe & CIS

  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in computer aided detection market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Computer Aided Detection Market

4. Voice of Customer

5. Executive Summary

6. Global Computer Aided Detection Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Imaging Modality (Mammography, MRI, Ultrasound, Tomosynthesis, Others)
    • 6.2.2. By Application (Oncology, Cardiovascular Diseases, Neurological Disorders)
      • 6.2.2.1. By Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others)
    • 6.2.3. By Company (2021)
    • 6.2.4. By Region
  • 6.3. Market Map

7. North America Computer Aided Detection Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Imaging Modality (Mammography, MRI, Ultrasound, Tomosynthesis, Others)
    • 7.2.2. By Application (Oncology, Cardiovascular Diseases, Neurological Disorders)
      • 7.2.2.1. By Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others)
    • 7.2.3. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Computer Aided Detection Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Imaging Modality
        • 7.3.1.2.2. By Application
    • 7.3.2. Mexico Computer Aided Detection Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Imaging Modality
        • 7.3.2.2.2. By Application
    • 7.3.3. Canada Computer Aided Detection Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Imaging Modality
        • 7.3.3.2.2. By Application

8. Europe Computer Aided Detection Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Imaging Modality (Mammography, MRI, Ultrasound, Tomosynthesis, Others)
    • 8.2.2. By Application (Oncology, Cardiovascular Diseases, Neurological Disorders)
      • 8.2.2.1. By Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others)
    • 8.2.3. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Computer Aided Detection Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Imaging Modality
        • 8.3.1.2.2. By Application
    • 8.3.2. Germany Computer Aided Detection Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Imaging Modality
        • 8.3.2.2.2. By Application
    • 8.3.3. United Kingdom Computer Aided Detection Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Imaging Modality
        • 8.3.3.2.2. By Application
    • 8.3.4. Italy Computer Aided Detection Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Imaging Modality
        • 8.3.4.2.2. By Application
    • 8.3.5. Spain Computer Aided Detection Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Imaging Modality
        • 8.3.5.2.2. By Application

9. Asia-Pacific Computer Aided Detection Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Imaging Modality (Mammography, MRI, Ultrasound, Tomosynthesis, Others)
    • 9.2.2. By Application (Oncology, Cardiovascular Diseases, Neurological Disorders)
      • 9.2.2.1. By Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others)
    • 9.2.3. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Computer Aided Detection Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Imaging Modality
        • 9.3.1.2.2. By Application
    • 9.3.2. India Computer Aided Detection Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Imaging Modality
        • 9.3.2.2.2. By Application
    • 9.3.3. Japan Computer Aided Detection Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Imaging Modality
        • 9.3.3.2.2. By Application
    • 9.3.4. South Korea Computer Aided Detection Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Imaging Modality
        • 9.3.4.2.2. By Application
    • 9.3.5. Australia Computer Aided Detection Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Imaging Modality
        • 9.3.5.2.2. By Application

10. South America Computer Aided Detection Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Imaging Modality (Mammography, MRI, Ultrasound, Tomosynthesis, Others)
    • 10.2.2. By Application (Oncology, Cardiovascular Diseases, Neurological Disorders)
      • 10.2.2.1. By Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others)
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Computer Aided Detection Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Imaging Modality
        • 10.3.1.2.2. By Application
    • 10.3.2. Argentina Computer Aided Detection Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Imaging Modality
        • 10.3.2.2.2. By Application
    • 10.3.3. Colombia Computer Aided Detection Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Imaging Modality
        • 10.3.3.2.2. By Application

11. Middle East and Africa Computer Aided Detection Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Imaging Modality (Mammography, MRI, Ultrasound, Tomosynthesis, Others)
    • 11.2.2. By Application (Oncology, Cardiovascular Diseases, Neurological Disorders)
      • 11.2.2.1. By Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others)
    • 11.2.3. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Computer Aided Detection Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Imaging Modality
        • 11.3.1.2.2. By Application
    • 11.3.2. Saudi Arabia Computer Aided Detection Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Imaging Modality
        • 11.3.2.2.2. By Application
    • 11.3.3. UAE Computer Aided Detection Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Imaging Modality
        • 11.3.3.2.2. By Application

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Hologic Inc.
  • 14.2. GE Healthcare
  • 14.3. Agfa-Gevaert N.V
  • 14.4. iCAD, Inc.
  • 14.5. Invivo Corporation
  • 14.6. McKesson Corporation
  • 14.7. Siemens Healthineers AG
  • 14.8. EDDA technology, Inc.
  • 14.9. FUJIFILM Medical Systems U.S.A., Inc.
  • 14.10. Koninklijke Philips N.V.

15. Strategic Recommendations